SuperworthStryker market cap SYK
Share price times shares outstanding: what the whole company sells for, since 2009.
- Today, Oct 23, 2026
- $117.8B
- Highest close in our data
- $154.2B
- Jul 2025
Stryker is worth $117.8B at the close on Oct 23, 2026, at $307.15 a share.
That is down 19% over the last year and up 17% over five years.
Its highest close in our data was $154.2B in Jul 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $117.8B | $104.5B | $148.3B | −13% |
| 2025 | $135.5B | $132B | $154.2B | −3% |
| 2024 | $139.9B | $112.2B | $149.5B | +23% |
| 2023 | $113.8B | $96.2B | $115.8B | +23% |
| 2022 | $92.5B | $73.4B | $101.7B | −8% |
| 2021 | $100.9B | $83.1B | $104.3B | +10% |
| 2020 | $92.1B | $52.2B | $92.1B | +17% |
| 2019 | $78.8B | $58.8B | $82.8B | +36% |
| 2018 | $57.9B | $56.4B | $66.9B | −0% |
| 2017 | $57.9B | $44.1B | $59.8B | +29% |
| 2016 | $44.9B | $33B | $45.7B | +29% |
| 2015 | $34.9B | $34.1B | $39B | −4% |
| 2014 | $36.2B | $28.3B | $36.2B | +27% |
| 2013 | $28.4B | $21.6B | $28.4B | +37% |
| 2012 | $20.7B | $19.1B | $21.4B | +9% |
| 2011 | $19B | $17B | $24.9B | −11% |
| 2010 | $21.3B | $17.5B | $23.4B | +6% |
| 2009 | $20B | $17.3B | $20.6B | n/a |
Against its peers
Companies in Medical - Devices nearest Stryker's size, closest first, today.
| Company | Market cap |
|---|---|
| SYKStryker | $117.8B |
| MDTMedtronic | $122B |
| ABTAbbott Laboratories | $179.4B |
| BSXBoston Scientific | $66.2B |
| EWEdwards Lifesciences | $51.3B |
| GEHCGE HealthCare Technologies | $32.3B |
| DXCMDexCom | $29.4B |
| ZBHZimmer Biomet | $18.8B |
| Peer median | $51.3B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Stryker
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.